Genelex Overview

  • Founded
  • 1987
Founded
  • Status
  • Acquired/​Merged
  • Latest Deal Type
  • M&A
  • Financing Rounds
  • 1
  • Investments
  • 1

Genelex General Information

Description

Provider of drug sensitivity tests. The company offers DNA drug sensitivity tests and a personalized prescribing platform for doctors to avoid drug side effects and reactions.

Contact Information

Website
www.genelex.com
Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Corporate Backed or Acquired
Primary Industry
Other Pharmaceuticals and Biotechnology
Other Industries
Biotechnology
Parent Company
Primary Office
  • 3101 Western Avenue
  • Suite 100
  • Seattle, WA 98121
  • United States
+1 (800) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Genelex Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Genelex‘s full profile, request access.

Request a free trial

Genelex Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Provider of drug sensitivity tests. The company offers DNA drug sensitivity tests and a personalized prescribing platfor
Other Pharmaceuticals and Biotechnology
Seattle, WA
00.00 0000-00-00
000000&0

0000000

piscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim ve
0000000000000
Charleston, SC
00 As of 0000
00.000
0000000000.

000000

itation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehende
0000000000000
Minneapolis, MN
00 As of 0000
00.000
0000000000 0 00.000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Genelex Competitors (2)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Iverson Genetic Diagnostics Formerly Angel backed Charleston, SC 00 00.000 0000000000.
000000 Venture Capital-Backed Minneapolis, MN 00 00.000 0000000000 0 00.000
You’re viewing 2 of 2 competitors. Get the full list »

Genelex Executive Team (6)

Name Title Board Seat Contact Info
Christopher Howlett Chief Executive Officer
Robert Patterson MD Chief Informatics Officer
Tia Aulinskas Ph.D Co-Founder, Chief Scientific Officer and Lab Director
Howard Coleman Co-Founder
You’re viewing 4 of 6 executive team members. Get the full list »

Genelex Acquisitions (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
000000 000000 0000 08-Jun-2010 000000000000000000 Other Healthcare Technology Systems 000000 0000000
To view Genelex’s complete acquisitions history, request access »